1Ruffini E, Mancuso M, Oliaro A, et al. Recurrence of thymoma: analysis of clinicopathologic features, treatment, and outcome. J Thorac Cardiovasc Surg, 1997, 113:55-63.
2Haniuda M, Morimoto M, Nishimura H, et al. Adjuvant radiotherapy after complete resection of thymoma. Ann Thorac Surg, 1992 , 54: 311-315.
3Mornex F, Resbeut M, Richaud P, et al. Radiotherapy and chemotherapy for invasive thymomas: a multicentric retrospective review of 90 cases. The FNCLCC trialists. Federation Nationale des Centres de Lutte Contre le Cancer. Int J Radiat Oncol Biol Phys, 1995, 32: 651-659.
4AisnerJ. Pleura and mediastinum. Abeloff MD.临床肿瘤学. 第2版[M].北京:科学出版社,2001.1494-1497.
5Hoffacker V, Schultz A, Tiesinga JJ, et al . Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated autoimmune disease. Blood, 2000 , 96: 3872-3879.
7Lastoria S, Vergara E, Palmieri G, et al. In vivo detection of malignant thymic masses by indium-111-DTPA-D-Phe1-octreotide scintigraphy. J Nucl Med, 1998, 39: 634-639.
8Han J, Lee KS, Yi CA, et al. Thymic epithelial tumors classified according to a newly established WHO scheme: CT and MR findings. Korean J Radiol, 2003,4:46-53.
9Okumura M, Ohta M, Tateyama H, et al. The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients.Cancer, 2002, 94: 624-632.
10Kondo K, Monden Y. Therapy for thymic epithelial tumors: a clinical study of 1320 patients from Japan. Ann Thorac Surg, 2003, 76: 878-884.
